•
Sep 30, 2022

IGM Biosciences Q3 2022 Earnings Report

Total Revenue
$331K
EPS
-$1.32
Previous year: -$1.32
+0.0%
Cash and Equivalents
$177M
Previous year: $166M
+7.1%
Free Cash Flow
-$43.1M
Previous year: -$37.1M
+16.4%
Total Assets
$541M
Previous year: $332M
+62.8%

IGM Biosciences

IGM Biosciences